The American Society of Dermatopathology

Founders' Award

Established by The American Society of Dermatopathology in 1983 in honor of the Founding Members of the Society, this endowed award is conceived to recognize individuals who have made outstanding original and significant contributions to the field of dermatopathology.

Congratulations to the 2022 Founders’ Award Recipient

Boris C. Bastian, MD, PhD
Departments of Dermatology and Pathology
Gerson & Barbara Bass Baker Distinguished Professor of Cancer Biology
Helen Diller Family Comprehensive Cancer Center

University of California, San Francisco

Dr. Boris Bastian received his MD degree and medical doctorate degree from the Ludwig-Maximilian University of Munich. After completing a residency in dermatology at the University of W├╝rzburg, he received additional training in dermatopathology and completed a postdoctoral fellowship in cancer genetics at the University of California, San Francisco before joining the institution’s faculty and starting his research laboratory at UCSF’s Helen Diller Family Comprehensive Cancer Center. In 2010 he moved to the Memorial Sloan-Kettering Cancer Center to become Chairman of the Department of Pathology. In 2011 he returned to UCSF where he holds the title of Gerson and Barbara Bakar Distinguished Professor of Cancer Biology. He is a faculty member of the Dermatopathology Division of the Departments of Dermatology and Pathology and oversees its molecular diagnostic laboratory. He also founded and directed the Clinical Cancer Genomics Laboratory at UCSF, which performs molecular diagnostics for UCSF cancer patients.

His research focuses on the molecular genetics of cutaneous neoplasms, with a particular emphasis on the discovery of genetic alterations useful for diagnosis, classification, and therapy. His laboratory has contributed to the discovery of multiple melanoma oncogenes and tumor suppressor genes, delineated genetic differences between melanoma subtypes and the development of novel tools to assist in the diagnosis of histopathologically ambiguous melanocytic neoplasms. He and his colleagues have characterized the sequential order in which genetic alterations become selected as melanomas evolve from precursor lesions such as melanocytic nevi. Based on these findings he has proposed an integrated taxonomy of melanocytic neoplasms, which integrates molecular, clinical, and histopathological features which has become the basis of the current WHO classification of melanocytic neoplasms. He served as the President of the Society of Melanoma Research from 2010 to 2013 and has received numerous awards for his work including the election to the German National Academy of Sciences, the Lila Gruber Award for Cancer Research of the American Academy of Dermatology, and an Outstanding Investigator Award of the National Cancer Institute.

Past Recipients of the Founders' Award

2021 Klaus J. Busam, MD
2020 Joan Guitart, MD
2019 Philip H. McKee, MD, FRCPath
2018 James W. Patterson, MD
2017 Clifton R. White, MD
2016 Christopher R. Shea, MD
2015 Lorenzo Cerroni, MD
2014 Thomas D. Horn, MD
2013 Dirk M. Elston, MD
2012 Ronald P. Rapini, MD
2011 Raymond L. Barnhill, MD
2010 Daniel J. Santa Cruz, MD
2009 Antoinette F. Hood, MD
2008 Jag Bhawan, MD
2007 Wilma F. Bergfeld, MD, FACP
2006 Ronald J. Barr, MD
2005 David D. Weedon, AO, MD, FRCPA
2004 Philip E. LeBoit, MD
2003 Ernst H. Beutner, PhD
2002 John C. Maize, MD
2001 Franz M. Enzinger, MD
2000 Waine C. Johnson, MD
1999 Loren E. Golitz, MD
1998 Martin C. Mihm, Jr., MD
1997 Edward Wilson Jones, FRCP, FRCPath
1996 John R. Haserick, MD
1995 Herbert Z. Lund, MD
1993 Richard J. Reed, MD
1992 John T. Headington, MD
1991 Robert G. Freeman, MD
1990 James H. Graham, MD
1989 A. Bernard Ackerman, MD
1988 Wallace H. Clark, Jr., MD
1987 Richard K. Winkelmann, MD
1986 Walter F. Lever, MD
1985 Elson B. Helwig, MD
1984 Hermann Pinkus, MD